Related Experiment Videos

Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic

Fabio de Souza1, Elizabeth Silaid Muxfeldt, Gil Fernando Salles

  • 1Internal Medicine Department, University Hospital Clementino Fraga Filho, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Expert Review of Cardiovascular Therapy
|August 17, 2012
PubMed

Insights

Resistant hypertension (RH) is a serious condition where blood pressure remains high despite medication. Ambulatory blood pressure monitoring and specific ECG/renal markers are key for predicting cardiovascular risks in RH patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Resistant hypertension (RH) affects many but remains understudied with an unclear prognosis.
  • Uncontrolled office blood pressure (BP) despite three medications defines RH.
  • Current understanding of RH prognosis and risk stratification needs improvement.

Purpose of the Study:

  • To evaluate the prognostic value of ambulatory BP monitoring, ECG, and renal parameters in RH.
  • To identify key predictors of cardiovascular morbidity and mortality in RH patients.
  • To explore novel markers for improved cardiovascular risk stratification in RH.

Main Methods:

  • Analysis of prospective studies on ambulatory BP monitoring.
  • Evaluation of ECG parameters like ventricular repolarization and left ventricular hypertrophy.
  • Assessment of renal parameters including albuminuria and glomerular filtration rate.

Main Results:

  • Ambulatory BPs are significant predictors of cardiovascular outcomes, unlike office BP.
  • True RH diagnosis and nondipping patterns predict cardiovascular events.
  • ECG findings (e.g., LVH) and renal markers (e.g., albuminuria) are potent cardiovascular risk markers in RH.

Conclusions:

  • Ambulatory BP monitoring is crucial for prognosis in RH.
  • Specific ECG and renal parameters significantly enhance cardiovascular risk assessment in RH.
  • Further research into markers like arterial stiffness and biomarkers may refine RH risk stratification.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...